GemVax&KAELLtd Balance Sheet Health
Financial Health criteria checks 5/6
GemVax&KAELLtd has a total shareholder equity of ₩73.9B and total debt of ₩35.2B, which brings its debt-to-equity ratio to 47.7%. Its total assets and total liabilities are ₩137.0B and ₩63.2B respectively.
Key information
47.7%
Debt to equity ratio
₩35.25b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩32.78b |
| Equity | ₩73.89b |
| Total liabilities | ₩63.15b |
| Total assets | ₩137.04b |
Recent financial health updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
Jul 05
GemVax&KAELLtd's (KOSDAQ:082270) Earnings Are Weaker Than They Seem
Apr 03Is GemVax&KAELLtd (KOSDAQ:082270) A Risky Investment?
Feb 17Investors Who Bought GemVax&KAELLtd (KOSDAQ:082270) Shares Three Years Ago Are Now Up 52%
Dec 26
Financial Position Analysis
Short Term Liabilities: A082270's short term assets (₩47.3B) exceed its short term liabilities (₩34.1B).
Long Term Liabilities: A082270's short term assets (₩47.3B) exceed its long term liabilities (₩29.0B).
Debt to Equity History and Analysis
Debt Level: A082270's net debt to equity ratio (3.3%) is considered satisfactory.
Reducing Debt: A082270's debt to equity ratio has increased from 27.9% to 47.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A082270 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A082270 has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 39.7% each year.